EVE Health Group Appoints First Member of New Scientific Advisory Board

Small Caps

Sep 15

EVE Health Group (ASX: EVE) has appointed senior research scientist Dr Fiona Cousins as the inaugural member of its new scientific advisory board. Dr Cousins has more than a decade of experience in ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2567790165"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2567790165\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2567790165?lang=en_US&edition=fundamental","thumbnail":"https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/09/EVE-Health-Group-ASX-Appoints-First-Member-New-Scientific-Advisory-Board.jpg","is_english":true,"pubTime":"2025-09-15 08:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2567790165","market":"hk","top_or_hot":-1,"title":"EVE Health Group Appoints First Member of New Scientific Advisory Board","media":"Small Caps","content":"<div>\n<p>EVE Health Group (ASX: EVE) has appointed senior research scientist Dr Fiona Cousins as the inaugural member of its new scientific advisory board.\nDr Cousins has more than a decade of experience in ...</p>\n\n<a href=\"https://smallcaps.com.au/eve-health-group-appoints-first-member-of-new-scientific-advisory-board/\">Source Link</a>\n\n</div>\n","source":"smallcap_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EVE Health Group Appoints First Member of New Scientific Advisory Board</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEVE Health Group Appoints First Member of New Scientific Advisory Board\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-09-15 08:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://smallcaps.com.au/eve-health-group-appoints-first-member-of-new-scientific-advisory-board/><strong>Small Caps</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>EVE Health Group (ASX: EVE) has appointed senior research scientist Dr Fiona Cousins as the inaugural member of its new scientific advisory board.\nDr Cousins has more than a decade of experience in ...</p>\n\n<a href=\"https://smallcaps.com.au/eve-health-group-appoints-first-member-of-new-scientific-advisory-board/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7141","symbol_name":"包装食品与肉类","start_time":0,"source_url":"https://smallcaps.com.au/eve-health-group-appoints-first-member-of-new-scientific-advisory-board/","article_id":"2567790165","we_media_id":null,"thumbnails":["https://cdn.shortpixel.ai/client/w_868,q_lossy,to_auto,ret_wait/https://150309019.v2.pressablecdn.com/wp-content/uploads/2025/09/EVE-Health-Group-ASX-Appoints-First-Member-New-Scientific-Advisory-Board.jpg"],"rights":{"source":"smallcap_stock","url":"https://smallcaps.com.au/eve-health-group-appoints-first-member-of-new-scientific-advisory-board/","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2567790165","pubTimestamp":1757895576,"columns":[],"sourceInfo":{"source_id":"smallcap_stock","name":"Small Caps"},"weMediaInfo":null,"summary":"EVE Health Group  has appointed senior research scientist Dr Fiona Cousins as the inaugural member of its new scientific advisory board.Dr Cousins has more than a decade of experience in reproductive biology and women’s health research, and currently works at The Ritchie Centre within the Hudson Institute of Medical Research in Victoria, focusing on inflammation and its role in endometriosis pathogenesis and identifying new therapeutic targets for endometriosis treatment.She holds a PhD in reproductive biology from the University of Edinburgh and has published extensively on endometrial regulation and dysfunction and endometriosis disease pathogenesis.The appointment provides EVE with internationally-recognised expertise to help shape its research and development pipeline, with particular relevance to dysmenorrhoea  and endometriosis, which are among the most prevalent and under-addressed conditions affecting women’s health.The company has established the scientific advisory board to p","collect":0,"end_time":0,"defaultTopTitle":"smallcaps.com.au","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7141":"包装食品与肉类","EVE.AU":"Eve Health Ltd","EVE":"EVe Mobility Acquisition Corp"},"translate_title":"EVE Health Group任命新科学顾问委员会第一位成员","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EVE":1,"EVE.AU":1},"content_text":"EVE Health Group (ASX: EVE) has appointed senior research scientist Dr Fiona Cousins as the inaugural member of its new scientific advisory board.\nDr Cousins has more than a decade of experience in reproductive biology and women’s health research, and currently works at The Ritchie Centre within the Hudson Institute of Medical Research in Victoria, focusing on inflammation and its role in endometriosis pathogenesis and identifying new therapeutic targets for endometriosis treatment.\nShe holds a PhD in reproductive biology from the University of Edinburgh and has published extensively on endometrial regulation and dysfunction and endometriosis disease pathogenesis.\nWomen’s Health Pipeline\nThe appointment provides EVE with internationally-recognised expertise to help shape its research and development pipeline, with particular relevance to dysmenorrhoea (painful menstruation) and endometriosis, which are among the most prevalent and under-addressed conditions affecting women’s health.\nThe company has established the scientific advisory board to provide independent strategic, scientific and clinical guidance to EVE’s executive management team and support the development and evaluation of evidence-based pharmaceutical and wellness products.\nBoard members will contribute to research, clinical practice, and product development towards EVE’s decisions on formulation strategy, target indications, regulatory positioning, and consumer uptake.\nDyspro Launch Imminent\nEVE executive director and chief scientific officer Dr Stuart Gunzburg said Dr Cousins’ appointment comes at a pivotal time as the company prepares to launch proprietary cannabinoid-based gummy formulation Dyspro for the treatment of dysmenorrhoea.\n“Fiona’s expertise in endometrial biology and endometriosis will be valuable as we take Dyspro through commercial launch and advance our pipeline of women’s health products,” he said.\n“Her appointment marks a milestone in strengthening the scientific foundation that underpins our strategy.”\nThe SAB has an important role in providing independent scientific advice to support EVE’s development programs, [and] I look forward to contributing my expertise in women’s reproductive health to help shape the company’s broader research and development efforts,” Dr Cousins added.\nEconomic Impact\nA recent study found that 77% of women aged between 18 years and 44 years reported painful menstrual symptoms that significantly impact their daily activities, with 44% of respondents missing days of work or study.\nThe economic implications are substantial, with the annual burden of menstrual symptoms in Australia approximately $14.2 billion, primarily due to lost productivity.\nIn more severe cases, dysmenorrhoea may be associated with endometriosis, which is a chronic inflammatory condition estimated to affect up to 14% of women of reproductive age.\nThe global dysmenorrhoea treatment market reached $16.42b in 2024, and analysts forecast it to grow at a compound annual rate of 5.73% to reach $30.12b by 2035, .","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}